# Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia

> **NCT07182890** · PHASE4 · RECRUITING · sponsor: **Xijing Hospital of Digestive Diseases** · enrollment: 180 (estimated)

## Conditions studied

- Functional Dyspepsia
- Probiotics
- Depression
- Anxiety

## Interventions

- **DRUG:** Clostridium butyricum
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT07182890
- **Lead sponsor:** Xijing Hospital of Digestive Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-20
- **Primary completion:** 2026-10-30
- **Final completion:** 2027-05-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07182890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07182890, "Efficacy of Clostridium Butyricum in Alleviating Anxiety and Depression in Patients With Functional Dyspepsia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07182890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*